🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center
Start Date
1996-02
Trial ID
NCT00003009
Treatments Being Tested
Type 1 diabetes (T1D) is the most common severe autoimmune disease worldwid...
Status
Completed
Location
Wellcome Trust Clinical Research Facility, Addenbrookes Hospital
Start Date
2014-10-03
Trial ID
NCT02265809
Treatments Being Tested
RATIONALE: Biological therapies, such as MDX-010, work in different ways to...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2003-02
Trial ID
NCT00058279
Treatments Being Tested
This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Start Date
2019-08-07
Trial ID
NCT04055623
RATIONALE: Giving autologous lymphocytes that have been treated in the labo...
Status
Terminated
Location
Roger Williams Medical Center
Start Date
2007-11
Trial ID
NCT00569296
Treatments Being Tested
The primary objective of this Phase 1 clinical trial is to evaluate the fea...
Status
Recruiting
Location
Department of Oncology
Start Date
2025-04-01
Trial ID
NCT06204991
Treatments Being Tested
This randomized phase II trial studies how well giving pembrolizumab with s...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-08-07
Trial ID
NCT02500576
This is a first in human, single arm, open label, Phase 1a/1b study to dete...
Status
Suspended
Location
City of Hope
Start Date
2019-07-03
Trial ID
NCT03970382
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Herbert Irving Comprehensive Cancer Center at Columbia University
Start Date
1999-03
Trial ID
NCT00008190
Adoptive T cell therapy with tumor infiltrating lymphocytes (TIL) has achie...
Status
Completed
Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Start Date
2015-07
Trial ID
NCT02482090
Treatments Being Tested